PTN Palatin Technologies Inc.

-0.01  -2%
Previous Close 0.73
Open 0.73
Price To Book 6
Market Cap 146205669
Shares 203,063,429
Volume 949,906
Short Ratio 12.78
Av. Daily Volume 934,424

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA date March 23, 2019 but noted November 13, 2018 that a 3-6 month delay is likely due to FDA request for further data.
Vyleesi (Bremelanotide)
Female sexual dysfunction (FSD)
Phase 2 trial to commence 1H 2019.
Heart failure
Phase 1 data due 4Q 2018.
Inflammatory bowel diseases

Latest News

  1. Edited Transcript of PTN earnings conference call or presentation 13-Nov-18 4:00pm GMT
  2. Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC — Emerging Consolidated Expectations, Analyst Ratings
  3. Here’s What Palatin Technologies Inc’s (NYSEMKT:PTN) P/E Ratio Is Telling Us
  4. What Kind Of Shareholders Own Palatin Technologies Inc (NYSEMKT:PTN)?
  5. Palatin Technologies, Inc. Reports First Fiscal Quarter 2019 Results and Provides Corporate Update
  6. Why Palatin Technologies Inc (NYSEMKT:PTN) Looks Like A Quality Company
  7. Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist
  8. Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on November 13, 2018
  9. Earnings Preview: Palatin (PTN) Q1 Earnings Expected to Decline
  10. Recent Analysis Shows Booz Allen Hamilton Holding, j2 Global, Leidos, The Hain Celestial Group, Palatin Technologies, and Marsh & McLennan Companies Market Influences — Renewed Outlook, Key Drivers of Growth
  11. Edited Transcript of PTN earnings conference call or presentation 13-Sep-18 3:00pm GMT
  12. Should You Be Tempted To Buy Poltronic SA (WSE:PTN) Because Of Its PE Ratio?
  13. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results
  14. Palatin Technologies Inc (NYSEMKT:PTN): Risks You Need To Consider Before Buying
  15. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018
  16. The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
  17. Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks
  18. Palatin Technologies Added to Russell 3000® Index
  19. Today's Research Reports on Stocks to Watch: 22nd Century Group and Palatin Technologies